Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03133637 · ClinicalTrials.gov registry record
Ceftriaxone and Jaundice in Neonates
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 27
- Enrollment target
NCT03133637 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 27 participants.
The verdict
NCT03133637 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for sepsis and investigators will observe the effect on jaundice.
Interventions
- DRUG ceftriaxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03133637
The ClinicalTrials.gov registry entry for NCT03133637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ceftriaxone is the first listed.
NCT03133637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03133637 about?
NCT03133637 is a clinical study titled "Ceftriaxone and Jaundice in Neonates". Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for sepsis and investigators will observe the effect on jaundice.
What is the current status of trial NCT03133637?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2016-03. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT03133637?
The interventions under investigation include: ceftriaxone (DRUG).
Who is sponsoring clinical trial NCT03133637?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.